openPR Logo
Press release

Heart Bear emerge at Wireless

01-08-2007 02:10 PM CET | IT, New Media & Software

Press release from: MOffY Ltd

Heart Bear

Heart Bear

Hong Kong 8th January 2007 - MOffY is delighted to announce Heart Bear launch in wireless. The Korean lovely Heart Bear, one of the main characters from CRZONE, is now available on mobile phones.
Heart Bear is the angel of love and it has accidentally fallen on the universe’s most beautiful planet – Earth.

Currently, the mobile digital contents including game, wallpaper, animation, theme, featured with Heart Bear are available from MOffY & partners at selected mobile network operators and mobile service providers in China, Taiwan, Hong Kong, Macau, Singapore, Malaysia, Thailand, Vietnam, Philippines, India, Brazil, Russia.

More java and WAP games will be available in the 1st quarter of 2007.

Ms. Amy Hui, the Business Manager of MOffY said that we see Heart Bear as one of the new heart winning mobile contents in Asia. And with the availability of Heart Bear’s merchandise in different markets, we are in no doubt that Heart Bear will be even more popular.

More information of Heart Bear is available at http://licensing.moffy.com/crzone/heart-bear.html

Flash Movie of Heart Bear is available at http://licensing.moffy.com/crzone/crzone-flash5.html
MOffY is the mobile content partner of Heart Bear as well as the worldwide licensing agent of Heart Bear. Heart Bear is open to all sorts of cooperation, manufacturers, merchandise, service marketing, packaging, gifts, printed articles, promotion and event marketing, and any potential cooperation.
For cooperation opportunity and marketing cooperation with MOffY on Heart Bear please contact the representative or your existing contacts.

Hong Kong
Ms. Natasha Meng Natasha@moffy.com
+852 8340 4655

Taiwan
Ms. Sibby Wong, sibby@moffy.com
+886 2 2731 7585

China
Ms. Hellen Zhang hellen@moffy.com
+86 137 0175 7041

South East Asia
Lily Qiu lily@moffy.com
+86 10 8407 4085

Other Markets
Mr. Alan Yung alan@moffy.com
+852 2174 1268

About CRZONE
http://www.crzone.com

About MOffY Limited
MOffY incorporated in Hong Kong has been in mobile contents development, distribution, publishing and consultation since 1999. Currently, MOffY with its content management system holds over 2000 games and application titles. Along with different types of mobile games, mobile games and applications are featured with famous characters, movie titles, and celebrities. MOffY is actively involved in mobile contents business, licensing and consulting. MOffY branded services channels are available in China, Hong Kong, Macao, Taiwan, Singapore, Malaysia, and Thailand.

http://www.iilcorp.com/corp/about-us.html
marketing@Moffy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Heart Bear emerge at Wireless here

News-ID: 14291 • Views: 3465

More Releases from MOffY Ltd

Merchandised Character reach the mobile in the Asia Pacific
BLOODY BUNNY from 2:Spot Communications are now available on mobile from MOffY Limited. . MOffY is now launching Bloody Bunny, Unsleep Sheep, Mission Banana, P 4 and the Escape Plan, Biscuit, DADA the Devils, Fluffy & Tilly, Braba Bear, Menmenboko, and Shadobo in the Greater China Region and South East Asia. BLOODY is the action bunny that comes to life to search for its
Eccentric “Hirumy” arrived Hong Kong and the Asia Pacific
7th August 2007 Hong Kong and Seoul - “Hirumy” with over 100 different personalities traits is now available from MOffY. De+Party and MOffY announced the cooperation to bring “Hirumy” mobile phone worldwide. “Hirumy” a girl of six year old, who want to become a top fashion model, keeps changing her personalities when she is in a different situation. There are always 2 characters, Good and Evil, fighting each
Mobile Comics Daily unveil in Taiwan
Mobile Comics Daily from MOffY featured with Big Comic Digital’s various comics is now launched at ABPW in Taiwan. Mobile Comics Daily is the service channel developed by MOffY under a cooperation with Big Comic Digital. The Mobile Comics Daily is also available on WAP, XHTML and I-mode in various mobile carriers in the Asia Pacific region. The Mobile Comics Daily featured with comic strip on a daily
I Love Egg emerge on mobile
Hong Kong and Seoul, 27th April 2007 - MOffY and D&H Inc, proudly announce I Love Egg arrival on mobile in China, Hong Kong, and South East Asia. I love Egg has been digital and merchandise markets in Korea and UK. Chinese Comic books of I Love Egg has published in Taiwan already. I Love Egg also appears on Cartoon Network in Japan. Now, MOffY has bring I love Egg

All 5 Releases


More Releases for Heart

Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an